`
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`www.uspto.gov
`
`NOTICE OF ALLOWANCE AND FEE(S) DUE
`
`10/29/2013
`7590
`51414
`GOODWIN PROCTER LLP
`PATENT ADMINISTRATOR
`53 ST A 1E STREET
`EXCHANGE PLACE
`BOSTON, MA 02109-2881
`
`EXAMINER
`
`WEDDINGTON, KEVIN E
`
`ART UNIT
`
`PAPER NUMBER
`
`1629
`
`DATE MAILED: 10/29/2013
`
`APPLICATION NO.
`
`FILING DATE
`
`FIRST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`13/046,118
`
`03111/2011
`
`Daniell, Rader
`
`AGP-002C2
`
`4237
`
`INVENTION: METHODS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH HYPERLIPIDEMIA AND
`TITLE OF
`HYPERCHOLESTEROLEMIA WHILE MINIMIZING SIDE EFFECTS
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`nonprovisiona1
`
`UNDISCOUNTED
`
`$1780
`
`$300
`
`$0
`
`$2080
`
`01129/2014
`
`THE APPLICATION IDENTIFIED ABOVE HAS BEEN EXAMINED AND IS ALLOWED FOR ISSUANCE AS A PATENT.
`PROSECUTION ON THE MERITS IS CLOSED. THIS NOTICE OF ALLOWANCE IS NOT A GRANT OF PATENT RIGHTS.
`THIS APPLICATION IS SUBJECT TO WITHDRAWAL FROM ISSUE AT THE INITIATIVE OF THE OFFICE OR UPON
`PETITION BY THE APPLICANT. SEE 37 CFR 1.313 AND MPEP 1308.
`
`THE ISSUE FEE AND PUBLICATION FEE (IF REQUIRED) MUST BE PAID WITHIN THREE MONTHS FROM THE
`MAILING DATE OF THIS NOTICE OR THIS APPLICATION SHALL BE REGARDED AS ABANDONED.
`THIS
`STATUTORY PERIOD CANNOT BE EXTENDED. SEE 35 U.S.C. 151. THE ISSUE FEE DUE INDICATED ABOVE DOES
`IF AN ISSUE FEE HAS
`NOT REFLECT A CREDIT FOR ANY PREVIOUSLY PAID ISSUE FEE IN THIS APPLICATION.
`PREVIOUSLY BEEN PAID IN THIS APPLICATION (AS SHOWN ABOVE), THE RETURN OF PART B OF THIS FORM
`WILL BE CONSIDERED A REQUEST TO REAPPLY THE PREVIOUSLY PAID ISSUE FEE TOWARD THE ISSUE FEE NOW
`DUE.
`
`HOW TO REPLY TO THIS NOTICE:
`
`L Review the ENTITY STATUS shown above, If the ENTITY STATUS is shown as SMALL or MICRO, verify whether entitlement to that
`entity status still applies,
`If the ENTITY STATUS is the same as shown above, pay the TOTAL FEE(S) DUE shown above,
`If the ENTITY STATUS is changed from that shown above, on PART B- FEE(S) TRANSMITTAL, complete section number 5 titled
`"Change in Entity Status (from status indicated above)",
`For purposes of this notice, small entity fees are 112 the amount of undiscounted fees, and micro entity fees are 112 the amount of small entity
`fees,
`
`IL PART B- FEE(S) TRANSMITTAL, or its equivalent, must be completed and returned to the United States Patent and Trademark Office
`(USPTO) with your ISSUE FEE and PUBLICATION FEE (if required), If you are charging the fee(s) to your deposit account, section "4b"
`of Part B - Fee(s) Transmittal should be completed and an extra copy of the form should be submitted, If an equivalent of Part B is filed, a
`request to reapply a previously paid issue fee must be clearly made, and delays in processing may occur due to the difficulty in recognizing
`the paper as an equivalent of Part B,
`
`IlL All communications regarding this application must give the application number, Please direct all communications prior to issuance to
`Mail Stop ISSUE FEE unless advised to the contrary,
`
`IMPORTANT REMINDER: Utility patents issuing on applications filed on or after Dec. 12, 1980 may require payment of
`maintenance fees. It is patentee's responsibility to ensure timely payment of maintenance fees when due.
`
`PTOL-85 (Rev, 02/11)
`
`Page 1 of 4
`
`
`
`PART B- FEE(S) TRANSMITTAL
`PART B - FEE(S) TRANSMITTAL
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Complete and send this form, together with applicable fee(s), to: Mail Mail Stop ISSUE FEE
`Commissioner for Patents
`Commissioner for Patents
`P.O. Box 1450
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`Alexandria, Virginia 22313-1450
`(571)-273-2885
`or Fax
`or @ (571)-273-2885
`
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any Change of address)
`CURRENT CORRESPONDENCE ADDRESS (Note: Use Block 1 for any change of address)
`
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks 1
`through 5 should be completed where
`INSTRUCTIONS: This form should be used for transmitting the ISSUE FEE and PUBLICATION FEE (if required). Blocks l through 5 should be completed where
`ap ropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`appropriate. All further correspondence including the Patent, advance orders and notification of maintenance fees will be mailed to the current correspondence address as
`indicated unless corrected below or directed otherwise in Block 1, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`indicated unless corrected below or directed otherwise in Block l, by (a) specifying a new correspondence address; and/or (b) indicating a separate "FEE ADDRESS" for
`maintenance fee notifications.
`maintenance fee notifications.
`Note: A certificate of mailin can only be used for domestic mailings of the
`Note: A certificate of mailing can only be used for domestic mailings of the
`Fee(s) Transmittal. This certi icate cannot be used for any ot ier accompanying
`Fee(s) Transmittal. This certificate cannot be used for any other accompanying
`apers. Each additional paper, such as an assignment or formal drawing, must
`papers. Each additional paper, such as an assignment or formal drawing, must
`have its own certificate of mailing or transmission.
`have its own certificate of mailing or transmission.
`Certificate of Mailing or Transmission
`Certificate of Mailing or Transmission
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`I hereby certify that this Fee(s) Transmittal is being deposited with the United
`States Postal Service with sufficient postage for first class mail in an envelope
`States Postal Service with sufficient postage for first class mail in an envelope
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`addressed to the Mail Stop ISSUE FEE address above, or being facsimile
`transmitted to the USPTO (571) 2732885, on the date indicated below.
`transmitted to the USPTO (571) 273-2885, on the date indicated below.
`
`_
`51414
`590
`10/29/2013
`51414
`7590
`10/29/2013
`GOODWIN PROCTER LLP
`PATENT ADMINISTRATOR
`PATENT ADMINISTRATOR
`53 STATE STREET
`53 STATE STREET
`EXCHANGE PI ACE
`EXCHANGE PLACE
`BOSTON, MA 02109-2881
`BOSTON, MA 02109-2881
`
`‘D“P°‘“°" “W
`(Depositor's name)
`<Sisnawr=>
`(Signature)
`(Date)
`(Date)
`
`APPLICAT ON NO.
`
`FILING DATE
`
`F {ST NAMED INVENTOR
`
`ATTORNEY DOCKET NO.
`
`CONFIRMATION NO.
`
`ATTORNEY DOCKET NO.
`FIRST NAMED INVENTOR
`FILING DATE
`APPLICATION NO.
`AGP—002C2
`Daniel J. Rader
`03/11/2011
`13/046,118
`AGP-002C2
`13/046,118
`TITLE OF INVENTION: METHODS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH HYPERLIPIDEMIA AND
`DanielJ. Rader
`03/ll/2011
`HYPERCHOLES TEROLEMIA WHILE MINIMIZING SIDE EFFECTS
`TITLE OF
`INVENTION: METHODS FOR TREATING DISORDERS OR DISEASES ASSOCIATED WITH HYPERLIPIDEMIA AND
`HYPERCHOLESTEROLEMIA WHILE MINIMIZING SIDE EFFECTS
`
`CONFIRMATION NO.
`4237
`4237
`
`APPLN. TYPE
`
`ENTITY STATUS
`
`ISSUE FEE DUE
`
`PUBLICATION FEE DUE
`
`PREV. PAID ISSUE FEE
`
`TOTAL FEE(S) DUE
`
`DATE DUE
`
`APPLN. TYPE
`nonprovisional
`nonprovisional
`
`ENTITY STATUS
`UNDISCOUNTED
`UNDISCOUNTED
`EXAMINER
`
`ISSUE FEE DUE
`S1780
`$1780
`ART UNIT
`
`PUBLICATION FEE DUE PREV. PAID ISSUE FEE
`$300
`510
`$300
`$0
`CLASS-SUB CLASS
`
`TOTAL FEE(S) DUE
`$2080
`$2080
`
`DATE DUE
`01/29/2014
`Ol/29/2014
`
`WEDDINGTON, KEVIN E
`EXAMINER
`
`1629
`ART UNIT
`
`514—321000
`CLASS-SUBCLASS
`
`514-321000
`WEDDINGTON, KEVIN E
`1629
`2. For printing on the patent front page, list
`1. Change of correspondence address or indication of "Fee Address" (37
`.
`CFR 1.363).
`(1) the names of up to 3 registered patent attorneys
`l. Change of correspondence address or indication of "Fee Address" (37
`2. For printing on the patent front page, list
`or agents OR, alternatively,
`3 Chan e of correspondence address (or Change of Correspondence
`CFR 1.363).
`(l) the names of up to 3 registered patent attorneys
`0 Change of correspondence address (or Change of Correspondence
`(2) the name of a single firm (having as a member a
`Address Orm PTO/SB/122) attached‘
`or agents OR, alternatively,
`registered attorney or agent) and the names of up to
`:1 ‘Tee Address" indication (or “Fee Address" Indication form
`Address form PTO/SB/122) attached.
`Fegisteftid P311911} '¢m0F11e_YS OF ag311tS- If 110 name 15
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`(2) the name of a single firm (having as a member a
`0 "Fee Address" indication (or "Fee Address" Indication form
`listed, no name will be printed.
`Number is 1-equil-ed_
`registered attorney or agent) and the names of up to
`2 registered patent attorneys or agents. If no name is
`PTO/SB/47; Rev 03-02 or more recent) attached. Use of a Customer
`listed, no name will be printed.
`Number is required.
`3. ASSIGNEE NAME AQID RESID<NC < DATA TO BE PRINT ‘D ON TH‘ PATENT (print or type)
`If an assignee is identified below, the document has been filed for
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent.
`3. ASSIGNEE NAME AND RESIDENCE DATA TO BE PRINTED ON THE PATENT (print or type)
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(A) NAME OF ASSIGNEE
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`PLEASE NOTE: Unless an assignee is identified below, no assignee data will appear on the patent. If an assignee is identified below, the document has been filed for
`recordation as set forth in 37 CFR 3.11. Completion of this form is NOT a substitute for filing an assignment.
`(B) RESIDENCE: (CITY and STATE OR COUNTRY)
`(A) NAME OF ASSIGNEE
`
`3 ________________________ _
`
`2 ________________________ _
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) :
`
`1: Individual 1: Corporation or other private group entity 1: Government
`
`Please check the appropriate assignee category or categories (will not be printed on the patent) : 0 Individual 0 Corporation or other private group entity 0 Government
`4a. The following fee(s) are submitted:
`4b. Payment of Fee(s): (Please first reapply any previously paid issue fee shown above)
`3 Issue Fee
`D A check is enclosed.
`4a. The following fee(s) are submitted:
`4b. Payment ofFee(s): (Please first reapply any previously paid issue fee shown above)
`3 Publication Fee (No small entity discount permitted)
`D Payment by credit card. Form PTO—2038 is attached.
`0 Issue Fee
`0 A check is enclosed.
`3 Advance Order — # of Copies
`D The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any
`overpayment, to Deposit Account Number
`(enclose an extra copy of this form).
`0 Publication Fee (No small entity discount permitted)
`0 Payment by credit card. Form PT0-2038 is attached.
`0 The Director is hereby authorized to charge the required fee(s), any deficiency, or credit any
`0 Advance Order-# of Copies __ __ ___ __ _
`(enclose an extra copy of this form).
`overpayment, to Deposit Account Number
`
`PTOL—85 (Rev. 02/11)
`
`PTOL-85 (Rev. 02/ll)
`
`Page 2 of 4
`
`Page 2 of 4
`
`
`
`5. Change in Entity Status (from status indicated above)
`5. Change in Entity Status (from status indicated above)
`0 Applicant certifying micro entity status. See 37 CFR 1.29
`3 Applicant certifying micro entity status. See 37 CFR 1.29
`0 Applicant asserting small entity status. See 37 CFR 1.27
`3 Applicant asserting small entity status. See 37 CFR 1.27
`0 Applicant changing to regular undiscounted fee status.
`3 Applicant changing to regular undiscounted fee status.
`
`NOTE: Absent a valid certification of Micro Entity Status (see form PTO/SB/l5A and l5B), issue
`NOTE: Absent a valid certification of Micro Entity Status (see form PTO/SB/15A and 15B), issue
`fee payment in the micro entity amount will not be accepted at the risk of application abandonment.
`fee payment in the micro entity amount will not be accepted at the risk of application abandonnient.
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`NOTE: If the application was previously under micro entity status, checking this box will be taken
`to be a notification of loss of entitlement to micro entity status.
`to be a notification of loss of entitlement to micro entity status.
`NOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`NOTE: Checking this box will be taken to be a notification of loss of entitlement to small or micro
`entity status, as applicable.
`entity status, as applicable.
`NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party in
`NOTE: The Issue Fee and Publication Fee (if required) will not be accepted from anyone other than the applicant; a registered attorney or agent; or the assignee or other party in
`interest as shown by the records of the United States Patent and Trademark Office.
`interest as shown by the records of the United States Patent and Trademark Office.
`
`Authorized Signature
`Authorized Signature _______________________ _
`
`Date
`Date ____________________ _
`
`Registration No.
`Typed or printed name
`Registration No. ________________ _
`Typed or printed name ______________________ _
`This collection of information is required by 37 CFR 1.31 l. The information is re uired to obtain or retain a benefit by the public which is to file (and by the USPTO to process)
`This collection of information is required by 37 CFR 1.311. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process)
`an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. T is collection is estimated to take 12 minutes to complete, including gathering, preparing, and
`an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 12 minutes to complete, including gathering, preparing, and
`submitting the completed application form to the USPTO. Time will v
`‘ de endin upon the individual case. Any comments on the amount of time you require to complete
`submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete
`this form and/or su gestions for reducing this burden, should be sent toaffie Chief In ormation Officer, US. Patent and Trademark Office, US. Department of Commerce, P.O.
`this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O.
`Box 1450, Alexan ria, Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, PO. Box 1450,
`Box 1450, Alexandria, Virginia 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450,
`Alexandria, Virginia 22313-1450.
`Alexandria, Virginia 22313-1450.
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
`
`PTOL—85 (Rev. 02/11) Approved for use through 08/31/2013.
`
`Page 3 of 4
`
`OMB 0651-0033
`Page 3 of 4
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMM
`
`PTOL-85 (Rev. 02/ll) Approved for use through 08/3112013.
`
`OMB 0651-0033
`
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`
`
`
`UNITED STA 1ES p A 1ENT AND TRADEMARK OFFICE
`UNITED STATES PATENT AND TRADEMARK OEEICE
`
`APPLICATION NO.
`APPLICATION NO.
`13/046,118
`13/046,118
`
`FILING DATE
`FILING DATE
`03/11/2011
`03111/2011
`
`F {ST NAMED INVENTOR
`FIRST NAMED INVENTOR
`Daniel J. Rader
`Daniell. Rader
`
`10/29/2013
`7590
`51414
`GOODWIN PROCTER LLP
`GOODWIN PROCTER LLP
`PATENT ADMINISTRATOR
`PATENT ADMINISTRATOR
`53 STATE STREHI
`53 ST A 1E STREET
`EXCHANGE PLACE
`EXCHANGE PLACE
`BOSTON, MA 02109-2881
`BOSTON, MA 02109-2881
`
`UNITED STATES DEPARTMENT OF COMTVIERCE
`UNITED STATES DEPARTMENT OF COMMERCE
`United States Patent and Trademark Office
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`Address: COMMISSIONER FOR PATENTS
`P.O. Box 1450
`P.O. Box 1450
`Alexandria, Virginia 22313-1450
`Alexandria, Virginia 22313-1450
`www.uspLo.gov
`www.uspto.gov
`
`ATTORNEY DOCKET NO.
`ATTORNEY DOCKET NO.
`AGP—002C2
`AGP-002C2
`
`CONFIRMATION NO.
`CONFIRMATION NO.
`4237
`4237
`
`EXAMINER
`whDD1NGroN,1<hv1N E
`WEDDINGTON, KEVIN E
`
`ART UNIT
`1629
`1629
`DATE MAILED: 10/29/2013
`DATE MAILED: 10/29/2013
`
`PAPER NUMBER
`
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`Determination of Patent Term Adjustment under 35 U.S.C. 154 (b)
`(application filed on or after May 29, 2000)
`(application filed on or after May 29, 2000)
`
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`The Patent Term Adjustment to date is 0 day(s). If the issue fee is paid on the date that is three months after the
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half
`mailing date of this notice and the patent issues on the Tuesday before the date that is 28 weeks (six and a half
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`months) after the mailing date of this notice, the Patent Term Adjustment will be 0 day(s).
`
`If a Continued Prosecution Application (CPA) was filed in the aboVe—identified application, the filing date that
`If a Continued Prosecution Application (CPA) was filed in the above-identified application, the filing date that
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`determines Patent Term Adjustment is the filing date of the most recent CPA.
`
`Applicant will be able to obtain more detailed infonnation by accessing the Patent Application Information Retrieval
`Applicant will be able to obtain more detailed information by accessing the Patent Application Information Retrieval
`(PAIR) WEB site (http://pair.uspto.goV).
`(PAIR) WEB site (http://pair.uspto.gov).
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Any questions regarding the Patent Term Extension or Adjustment determination should be directed to the Office of
`Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at l—(888)—786—0l0l or (571)-272-4200.
`Patent Legal Administration at (571)-272-7702. Questions relating to issue and publication fee payments should be
`directed to the Customer Service Center of the Office of Patent Publication at 1-(888)-786-0 101 or (571 )-272-4200.
`
`PTOL—85 (Rev. 02/11)
`
`PTOL-85 (Rev. 02/11)
`
`Page 4 of 4
`
`Page 4 of 4
`
`
`
`Notice of Allowability
`
`Application No.
`13/046,118
`Examiner
`KEVIN E. WEDDINGTON
`
`Applicant(s)
`RADER, DANIEL J.
`Art Unit
`AlA (First Inventor to
`File) Status
`1 629
`No
`
`-- The MAILING DATE of this communication appears on the cover sheet with the correspondence address-(cid:173)
`All claims being allowable, PROSECUTION ON THE MERITS IS (OR REMAINS) CLOSED in this application. If not included
`herewith (or previously mailed), a Notice of Allowance (PTOL-85) or other appropriate communication will be mailed in due course. THIS
`NOTICE OF ALLOW ABILITY IS NOT A GRANT OF PATENT RIGHTS. This application is subject to withdrawal from issue at the initiative
`of the Office or upon petition by the applicant. See 37 CFR 1.313 and MPEP 1308.
`
`1. [gl This communication is responsive to September 25, 2013.
`D A declaration(s)/affidavit(s) under 37 CFR 1.130(b) was/were filed on ___ .
`2. D An election was made by the applicant in response to a restriction requirement set forth during the interview on __ ; the restriction
`requirement and election have been incorporated into this action.
`
`3. [gl The allowed claim(s) is/are 1-4. 6. B. 9. 13 and 26: renumbered 1-9. As a result of the allowed claim(s), you may be eligible to benefit
`from the Patent Prosecution Highway program at a participating intellectual property office for the corresponding application. For
`more information, please see htt.Q://www.usgto.gov/Qatents/init events/Q.Qh/index.isQ. or send an inquiry to PPHfeedback~us_Qto.gov.
`4. D Acknowledgment is made of a claim for foreign priority under 35 U.S.C. § 119(a)-(d) or (f).
`Certified copies:
`*c) D None of the:
`a) D All
`b) D Some
`1. D Certified copies of the priority documents have been received.
`2. D Certified copies of the priority documents have been received in Application No. __ .
`3. D Copies of the certified copies of the priority documents have been received in this national stage application from the
`International Bureau (PCT Rule 17.2(a)).
`* Certified copies not received: __ .
`
`Applicant has THREE MONTHS FROM THE "MAILING DATE" of this communication to file a reply complying with the requirements
`noted below. Failure to timely comply will result in ABANDONMENT of this application.
`THIS THREE-MONTH PERIOD IS NOT EXTENDABLE.
`5. D CORRECTED DRAWINGS (as "replacement sheets") must be submitted.
`D including changes required by the attached Examiner's Amendment I Comment or in the Office action of
`Paper No./Mail Date __ .
`Identifying indicia such as the application number {see 37 CFR 1.84{c)) should be written on the drawings in the front {not the back) of
`each sheet. Replacement sheet{s) should be labeled as such in the header according to 37 CFR 1.121 {d).
`6. 0 DEPOSIT OF and/or INFORMATION about the deposit of BIOLOGICAL MATERIAL must be submitted. Note the
`attached Examiner's comment regarding REQUIREMENT FOR THE DEPOSIT OF BIOLOGICAL MATERIAL.
`
`Attachment(s)
`1. D Notice of References Cited (PT0-892)
`2. [gilnformation Disclosure Statements (PTO/SB/08),
`Paper No./Mail Date 9/25/2013
`3. D Examiner's Comment Regarding Requirement for Deposit
`of Biological Material
`4. D Interview Summary (PT0-413),
`Paper No./Mail Date __ .
`
`/KEVIN E WEDDINGTON/
`Primary Examiner
`Art Unit: 1629
`
`5. D Examiner's Amendment/Comment
`6. D Examiner's Statement of Reasons for Allowance
`7. D Other __ .
`
`U.S. Patent and Trademark Off1ce
`PTOL-37 (Rev. 08-13)
`
`Notice of Allowability
`
`Part of Paper No./Mail Date 20131016